Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  von Groll, Andrea ^a   Martin, Anandi ^a   Stehr, Matthias ^b   Singh, Mahavir ^b   Portaels, Françoise ^a   da Silva, Pedro Eduardo Almeida ^c   Palomino, Juan Carlos ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; ISONIAZID; POLYSORBATE 80; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DNA EXTRACTION; GENOTYPE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; BACTERIUM IDENTIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING;

MYCOBACTERIUM TUBERCULOSIS;

BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS;

EID: 77956312287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010191     Document Type: Article

References (33)

1. World Health Organization (2009) Global Tuberculosis Control - Surveillance, Planning, Financing. URL: http://www.who.int. Accessed in 15/11/2009.
2. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN (2002) Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 10: 45-52.
3. Krüüner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, et al. (2001) Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 39: 3339-3345.
4. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, et al. (2005) Drug-Resistant Tuberculosis, Clinical Virulence, and the Dominance of the Beijing Strain Family in Russia. JAMA 293: 2726-2731.
5. Kubica T, Agzamova R, Wright A, Aziz MA, Rakishev G, et al. (2005) The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis 9: 646-653.
6. Caws M, Thwaites G, Stepniewska K (2006) Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous Meningitis. J Clin Microbiol 44: 3934-3939.
7. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis (2006) Beijing/ W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 12: 736-743.
8. Rad ME, Bifani P, Martin C, Kremer K, Samper S, et al. (2003) Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family. Emerg Infect Dis 9: 836-845.
9. Werngren J, Hoffner SE (2003) Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate. J Clin Microbiol 41: 1520-24.
10. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, et al. (2006) The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312: 1944-1946.
11. van Soolingen D, de Haas PEW, van Doorn HR, Kuijper E, Rinder H, et al. (2000) Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to Isoniazid, other drug resistance and successful transmission of Mycobacterium tuberculosis in The Netherlands. J Infec Dis 182: 1788-1790.
12. Mani C, Selvakumar N, Narayanan S, Narayanan PR (2001) Mutation in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 39: 2987-2990.
13. Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, et al. (2005) Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 9: 1161-1167.
14. Hazbón MH, Brimacombe M, del Valle MB, Cavatore M, Guerrero MI, et al. (2006) Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50: 2640-2649.
15. Pym AS, Saint-Joanis B, Cole ST (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70: 4955-4960.
16. Mariam DH, Mengistu Y, Hoffner SE, Andersson DI (2004) Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 48: 1289-1294.
17. Gagneux S (2009) Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 15: 66-68.
18. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6: 23-39.
19. Toungoussova OS, Caugant DA, Sandven P, Mariandyshev AO, Bjune G (2004) Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol 42: 281-290.
20. Rio lineage and LAM family of Mycobacterium tuberculosis in the city of Rio Grande, Brazil. FEMS Immunol Med Microbiol 58: 119-127.
21. Telenti A, Imboden P, Marchesi F, Matter L, Schopfer K, et al. (1993) Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341: 647-650.
22. Zhang Y, Heym B, Allen B, Young D, Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.
23. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
24. Lipsitch M, Levin BR (1998) Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Tuber Lung Dis 2: 187-199.
25. Billington OJ, McHugh TD, Gillespie SH (1999) Phisiological Cost of Rifampin Resistence Induced In Vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 43: 1866-1869.
26. Masaki S, Sugimori G, Okamoto A, Imose J, Hayashi Y (1991) Effect of Tween 80 on Formation of the Superficial L1 Layer of the Mycobacterium avium- Mycobacterium intracellulare Complex. J Clin Microbiol 29: 1453-1456.
27. Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, et al. (2004) Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 169: 610-614.
28. National Committee for Clinical and Laboratory Standards (2003) Susceptibility testing ofMycobacteria, Nocardia, and other aerobic actinomycetes. Volume 33, n°18, NCCLS M24-A. National Committee for Clinical and Laboratory Standards, Wayne, PA., USA.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous Detection and Strain Differentiation of Mycobacterium tuberculosis for Diagnosis and Epidemiology. J Clin Microbiol 35: 907-914.
30. Rigouts L, Nolasco O, Rijk P, Nduwamahoro E, Van Deun A, et al. (2007) Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 45: 252-254.
31. Kiepiela P, Bishop KS, Smith AN, Roux L, York DF (2000) Genomic mutations in the katG, inhA and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Int J Tuber Lung Dis 80: 47-56.
32. Miles AA, Misra SS (1938) The estimation of the bacteriocidal power of blood. J Hyg Camb 38: 732-749.
33. Hillemann D, Warren R, Kubica T, Rüsch-Gerdes S, NiemannS (2006) Rapid Detection of Mycobacterium tuberculosis Beijing Genotype Strains by Real-Time PCR. J Clin Microbiol 44: 302-306.